Abortion: Drugs

(asked on 25th February 2022) - View Source

Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment they have made of the impact of ending the home use of mifepristone on (1) waiting times, (2) workforce pressures, and (3) the long-term sustainability, of abortion services.


Answered by
Lord Kamall Portrait
Lord Kamall
This question was answered on 7th March 2022

Given current pressures on the sector, the Government has provided an extended period for services to plan for the return of face-to-face treatments. We will continue to work with NHS England and NHS Improvement, the Care Quality Commission and abortion providers to ensure a safe and reliable return to face-to-face services.

We are developing a new Sexual and Reproductive Health Strategy which will set out plans to improve reproductive health outcomes and wellbeing. Whilst issues relating to abortion legislation will not be in scope of the Strategy, ensuring the sustainability of accessible and high quality abortion services for women will be a priority.

Reticulating Splines